Triplet excited states as chiral reporter for the binding of drugs to transport proteins by Jiménez Molero, María Consuelo et al.
 Document downloaded from: 
 

























Jiménez Molero, MC.; Miranda Alonso, MÁ.; Vayá Pérez, I. (2005). Triplet excited states as
chiral reporter for the binding of drugs to transport proteins. Journal of the American




Triplet excited states as chiral reporters for the binding of drugs to transport proteins 
M. Consuelo Jiménez, Miguel A. Miranda* and Ignacio Vayá 
Departamento de Química-Instituto de Tecnología Química UPV-CSIC, Universidad Politécnica de Valencia, camino 
de Vera s/n, E-46022 Valencia, Spain. 
RECEIVED DATE (automatically inserted by publisher); e-mail: mmiranda@qim.upv.es
Human serum albumin (HSA) is the most important transport 
protein. One of its main functions is to carry different endogenous 
and exogenous agents (including drugs) around the blood-stream, 
in order to achieve their efficient and selective delivery to the 
specific targets.1  
The pioneering work performed by Sudlow and coworkers 
three decades ago revealed that there are two major and 
structurally selective binding sites in HSA, namely site I and site 
II. 2 Although more recent studies have found evidence supporting 
the existence of several subdomains, consensus still exists that 
there are basically two high affinity binding sites for small 
heterocyclic or aromatic compounds in this protein.3  
As the knowledge of drug-HSA interactions is essential for 
understanding the biodistribution, metabolism, elimination and 
pharmacological effect of drugs in the body, a number of 
techniques have been used to address this problem. They include 
equilibrium dialysis, ultrafiltration, ultracentrifugation, 
calorimetry, fluorescence quenching, circular dichroism, liquid 
chromatography, capillary electrophoresis, NMR diffusion 
measurements, etc.4,5 Each method presents advantages and 
limitations; the latter are mainly related to sensitivity, 
interferences, diffusion problems or lack of reproducibility arising 
from a complicated workup. 
Arylpropionic acid derivatives are the main group of non-
steroidal anti-inflammatory drugs (NSAIDs). They are currently 
marketed as racemic mixtures (with few exceptions such as 
naproxen); however, their anti-inflammatory activity is mainly 
attributed to the (S)-isomer.6 Those drugs bind preferentially (and 
often stereoselectively) to site II of HSA by means of hydrogen 
bonding and electrostatic interactions.7 Upon methylation of the 
carboxy group, binding occurs preferentially to site I, where 
hydrophobic interactions predominate.8 
The aim of the present work has been to explore the suitability 
of triplet excited states as chiral reporters for the important issue 
of drug binding to transport proteins. As the properties of these 
states are very sensitive to the experienced microenvironment,9 
they should allow to study the drug distribution among the bulk 
solution and the different protein binding sites. More 
interestingly, triplet lifetime measurements would provide 
valuable information on the nature of drug-HSA complexes, such 
as strength of the interaction, conformational restrictions, 
protection from attack by oxygen or other reagents, 
stereochemical requirements, etc. Previously, laser flash 
photolysis (LFP) has been employed for the study of carprofen-
HSA complexes.10 However, in this case fast reaction of the drug 
triplet state with the Trp unit of site I limits its possibilities to be 
used as a probe. In order to circumvent this problem, an “inert” 
triplet would be more adequate as reporter, while residing as 
observer in the HSA binding sites. Flurbiprofen (FBP) is a 
NSAID of the 2-arylpropionic acid class used for several medical 
purposes, such as the treatment of osteoarthritis, rheumatoid 
arthritis, post-operative dental pain and ocular disorders.11 The 
lowest triplet excited state of FBP has recently been 
characterized,12 and its lifetime has been found to be highly 
sensitive to the medium. In the present work, the triplet state of 
FBP methyl ester (FBPMe, Chart 1) has been used as probe for 
the binding sites of HSA. The choice of FBPMe has been done 
for experimental convenience, since its hydrophobic character 
should favor inclusion within HSA (preferentially in site I, as 
stated above). Both (R)- and (S)-FBPMe have been investigated in 
order to obtain valuable information about the possible 






 Aqueous solutions containing (S)-FBPMe and HSA (molar 
ratio from 10:1 to 0.5:1) were prepared in neutral buffer (0.01 M 
PBS) and submitted to laser flash photolysis. The transient 
absorption spectrum obtained after laser excitation (λexc = 266 
nm) of an aerated 2.5·10-5 M solution of (S)-FBPMe displayed a 
maximum at 360 nm, assigned to the first triplet excited state.12 Its 
decay (Figure 1) followed a first order exponential law with a 




















 Remarkably, in the presence of HSA this species lived much 
longer (see Figure 1) and did not exhibit a first order exponential 
decay. Thus, when the [(S)-FBPMe]/[HSA] ratio was between 1:1 
and 0.5:1, the signal followed a second order exponential decay 
with lifetimes of 4.1 and 31.5 µs. The negligible contribution of 
the 1.5 µs lifetime component indicated the absence of free (S)-
FBPMe in solution under these conditions.  
 It is noteworthy that protein-bound (S)-FBPMe has 
dramatically longer lifetimes than the non-complexed form (τT 
values up to 21 fold higher). This can be attributed to a slower 
Figure 1. Laser flash photolysis (λexc= 266 nm) of (S)-FBPMe (▲), 
(S)-FBPMe/HSA 2:1 (▲) and (S)-FBPMe/HSA 0.5:1 (▲) in 0.01 
M PBS. Normalized decays monitored at 360 nm. The concentration of 






















deactivation via non-radiative processes, due to important 
restrictions in the degrees of freedom inside the HSA binding 
sites, where a microenvironment is provided that protects the 
triplet excited state from attack by oxygen or other reagents. In 
this context, the fact that two different τT values were measured in 
the presence of HSA can be correlated with the existence of two 
types of binding sites. At higher [(S)-FBPMe]/[HSA] ratios (from 
1.25:1 to 10:1), three lifetimes values (1.5, 4.1 and 31.5 µs) were 
necessary to obtain a good fitting of the decay signal (also shown 
in Figure 1). This can be clearly associated with the presence of 
free (S)-FBPMe in solution, in addition to the two HSA-bound 
species.  
 Parallel experiments were carried out for (R)-FBPMe. In PBS 
solution the transient absorption spectra and the triplet lifetimes 
did not differ from those of the (S)- enantiomer. By contrast, 
when included within HSA, two components with τT 157.6 µs and 
16.6 µs were found for (R)-FBPMe. These values are much higher 
than those obtained for (S)-FBPMe, indicating a remarkable 
stereodifferentiation between the two enantiomers in the protein 
binding process. A comparison between the decays monitored at 
360 nm for (S)-FBPMe, (S)-FBPMe/HSA and (R)-FBPMe/HSA is 




















 Regression analysis of the decay curves for several 
[FBPMe]/[HSA] ratios was performed to obtain the values of the 
A1, A2 and A3 coefficients (components with different lifetimes). 
Based on the known fact that the high affinity site of 2-
arylpropionic acids methyl esters is site I,8 the major (longer-
lived) component under non-saturating conditions was assigned to 
FBPMe within this site; while the minor (shorter-lived) 
component was assigned to site II-bound FBPMe. In order to 
obtain independent evidence supporting this assignment, 
additional LFP experiments were performed in the presence of 
warfarin, a well established probe for site I.13 In agreement with 
our initial assumption, addition of this probe resulted in a reduced 
contribution of the longer lifetime components (attributed to site 
I). Thus, at 1:1.1 [FBPMe]/[HSA]/[warfarin] molar ratio this 
value dropped to ca. 50% (as compared with ca. 70% in the 
absence of warfarin). 
 The trends clearly show (Figure 3A) that, for the same 
[FBPMe]/[HSA] ratio, inclusion within HSA is slightly favored 
for the (S)- isomer. Besides, a significant stereodifferentiation is 
observed when comparing the occupation level of the two sites, 
with higher preference for site I in the case of (S)-FBPMe. In 
general, when the [FBPMe]/[HSA] ratio is low (far from 
saturation) all the drug is protein-bound and the high affinity site I 
is selectively populated. Progressive increase of the 
[FBPMe]/[HSA] ratio results in saturation of site I and 
(subsequently) site II. This leads to a decrease of site selectivity 
































In summary, the triplet excited state of FBPMe has been used 
as a chiral reporter for the two binding sites of HSA. The 
occupation level of the binding sites in HSA has been estimated 
from regression analysis of the triplet decays at several 
[FBPMe]/[HSA] ratios. A remarkable stereodifferentiation has 
been found in the triplet lifetimes within the protein 
microenvironment.  
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Figure 2. Laser flash photolysis (λexc= 266 nm) of (S)- or  (R)-FBPMe 
2.5·10-5 M (), as well as 1:1 solutions of (S)-FBPMe/HSA (●) and 
(R)-FBPMe/HSA (●) in 0.01 M PBS, under air. A: Spectra 
obtained 3.7 µs after the laser pulse. B: Decays monitored at 360 nm. 
Figure 3. A. Percent of (S)-FBPMe and (R)-FBPMe: free (white), in 
site I (green) and in site II (brown). B Percent of (R)-FBPMe (●) and 
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ABSTRACT FOR WEB PUBLICATION 
The triplet excited state of flurbiprofen methyl ester (FBPMe) has been used as a chiral reporter for the two binding sites of human 
serum albumin (HSA). The occupation level of the binding sites has been estimated from regression analysis of the triplet decays at 
several [FBPMe]/[HSA] ratios. The data agree with two high affinity binding sites (I and II) that are populated to a different extent. A 
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